 | • レポートコード：MRC2012B1290 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、鎌状赤血球貧血治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。鎌状赤血球貧血治療薬の種類別市場規模（輸血、薬物療法、骨髄移植）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：BioMarin、Modus Therapeutics、Emmaus Medical、Bluebird Bio、GlycoMimetics、DeuteRx、Sancilio Pharmaceuticals、Global Blood Therapeutics、Gamida Cell、Pfizer、Sangamo Biosciences、 ・地域別グローバル市場分析 2015年-2020年 ・鎌状赤血球貧血治療薬の北米市場（アメリカ、カナダ、メキシコ） ・鎌状赤血球貧血治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・鎌状赤血球貧血治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・鎌状赤血球貧血治療薬の南米市場（ブラジル、アルゼンチン） ・鎌状赤血球貧血治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：輸血、薬物療法、骨髄移植 ・用途別分析：病院、診療所、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Sickle Cell Anemia Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Sickle Cell Anemia Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.5%% in the forecast period of 2020 to 2025 and will expected to reach USD 4146.9 million by 2025, from USD 2778.8 million in 2019.
Market segmentation
Sickle Cell Anemia Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Sickle Cell Anemia Therapeutics market has been segmented into:
Blood Transfusion
Pharmacotherapy
Bone Marrow Transplant
By Application, Sickle Cell Anemia Therapeutics has been segmented into:
Hospitals
Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sickle Cell Anemia Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Sickle Cell Anemia Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sickle Cell Anemia Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Sickle Cell Anemia Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Sickle Cell Anemia Therapeutics Market Share Analysis
Sickle Cell Anemia Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sickle Cell Anemia Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sickle Cell Anemia Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Sickle Cell Anemia Therapeutics are:
BioMarin
Modus Therapeutics
Emmaus Medical
Bluebird Bio
GlycoMimetics
DeuteRx
Sancilio Pharmaceuticals
Global Blood Therapeutics
Gamida Cell
Pfizer
Sangamo Biosciences
Among other players domestic and global, Sickle Cell Anemia Therapeutics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Sickle Cell Anemia Therapeutics Market Overview
1.1 Product Overview and Scope of Sickle Cell Anemia Therapeutics
1.2 Classification of Sickle Cell Anemia Therapeutics by Type
1.2.1 Global Sickle Cell Anemia Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type in 2019
1.2.3 Blood Transfusion
1.2.4 Pharmacotherapy
1.2.5 Bone Marrow Transplant
1.3 Global Sickle Cell Anemia Therapeutics Market by Application
1.3.1 Overview: Global Sickle Cell Anemia Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Sickle Cell Anemia Therapeutics Market by Regions
1.4.1 Global Sickle Cell Anemia Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Sickle Cell Anemia Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Sickle Cell Anemia Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Sickle Cell Anemia Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sickle Cell Anemia Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Sickle Cell Anemia Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sickle Cell Anemia Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 BioMarin
2.1.1 BioMarin Details
2.1.2 BioMarin Major Business
2.1.3 BioMarin SWOT Analysis
2.1.4 BioMarin Product and Services
2.1.5 BioMarin Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Modus Therapeutics
2.2.1 Modus Therapeutics Details
2.2.2 Modus Therapeutics Major Business
2.2.3 Modus Therapeutics SWOT Analysis
2.2.4 Modus Therapeutics Product and Services
2.2.5 Modus Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Emmaus Medical
2.3.1 Emmaus Medical Details
2.3.2 Emmaus Medical Major Business
2.3.3 Emmaus Medical SWOT Analysis
2.3.4 Emmaus Medical Product and Services
2.3.5 Emmaus Medical Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bluebird Bio
2.4.1 Bluebird Bio Details
2.4.2 Bluebird Bio Major Business
2.4.3 Bluebird Bio SWOT Analysis
2.4.4 Bluebird Bio Product and Services
2.4.5 Bluebird Bio Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 GlycoMimetics
2.5.1 GlycoMimetics Details
2.5.2 GlycoMimetics Major Business
2.5.3 GlycoMimetics SWOT Analysis
2.5.4 GlycoMimetics Product and Services
2.5.5 GlycoMimetics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 DeuteRx
2.6.1 DeuteRx Details
2.6.2 DeuteRx Major Business
2.6.3 DeuteRx Product and Services
2.6.4 DeuteRx Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sancilio Pharmaceuticals
2.7.1 Sancilio Pharmaceuticals Details
2.7.2 Sancilio Pharmaceuticals Major Business
2.7.3 Sancilio Pharmaceuticals Product and Services
2.7.4 Sancilio Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Global Blood Therapeutics
2.8.1 Global Blood Therapeutics Details
2.8.2 Global Blood Therapeutics Major Business
2.8.3 Global Blood Therapeutics Product and Services
2.8.4 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Gamida Cell
2.9.1 Gamida Cell Details
2.9.2 Gamida Cell Major Business
2.9.3 Gamida Cell Product and Services
2.9.4 Gamida Cell Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Product and Services
2.10.4 Pfizer Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sangamo Biosciences
2.11.1 Sangamo Biosciences Details
2.11.2 Sangamo Biosciences Major Business
2.11.3 Sangamo Biosciences Product and Services
2.11.4 Sangamo Biosciences Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Sickle Cell Anemia Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Sickle Cell Anemia Therapeutics Players Market Share
3.2.2 Top 10 Sickle Cell Anemia Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Sickle Cell Anemia Therapeutics Revenue and Market Share by Regions
4.2 North America Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Sickle Cell Anemia Therapeutics Revenue by Countries
5.1 North America Sickle Cell Anemia Therapeutics Revenue by Countries (2015-2020)
5.2 USA Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Sickle Cell Anemia Therapeutics Revenue by Countries
6.1 Europe Sickle Cell Anemia Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Sickle Cell Anemia Therapeutics Revenue by Countries
7.1 Asia-Pacific Sickle Cell Anemia Therapeutics Revenue by Countries (2015-2020)
7.2 China Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Sickle Cell Anemia Therapeutics Revenue by Countries
8.1 South America Sickle Cell Anemia Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Sickle Cell Anemia Therapeutics by Countries
9.1 Middle East & Africa Sickle Cell Anemia Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Sickle Cell Anemia Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Sickle Cell Anemia Therapeutics Market Forecast by Type (2019-2024)
10.3 Blood Transfusion Revenue Growth Rate (2015-2025)
10.4 Pharmacotherapy Revenue Growth Rate (2015-2025)
10.5 Bone Marrow Transplant Revenue Growth Rate (2015-2025)
11 Global Sickle Cell Anemia Therapeutics Market Segment by Application
11.1 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Sickle Cell Anemia Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Sickle Cell Anemia Therapeutics Market Size Forecast (2021-2025)
12.1 Global Sickle Cell Anemia Therapeutics Market Size Forecast (2021-2025)
12.2 Global Sickle Cell Anemia Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Sickle Cell Anemia Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Sickle Cell Anemia Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Sickle Cell Anemia Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Sickle Cell Anemia Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Sickle Cell Anemia Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Sickle Cell Anemia Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sickle Cell Anemia Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sickle Cell Anemia Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Sickle Cell Anemia Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Sickle Cell Anemia Therapeutics Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. BioMarin Corporate Information, Location and Competitors
Table 7. BioMarin Sickle Cell Anemia Therapeutics Major Business
Table 8. BioMarin Sickle Cell Anemia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 9. BioMarin SWOT Analysis
Table 10. BioMarin Sickle Cell Anemia Therapeutics Product and Solutions
Table 11. BioMarin Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Modus Therapeutics Corporate Information, Location and Competitors
Table 13. Modus Therapeutics Sickle Cell Anemia Therapeutics Major Business
Table 14. Modus Therapeutics Sickle Cell Anemia Therapeutics Total Revenue (USD Million) (2018-2019)
Table 15. Modus Therapeutics SWOT Analysis
Table 16. Modus Therapeutics Sickle Cell Anemia Therapeutics Product and Solutions
Table 17. Modus Therapeutics Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Emmaus Medical Corporate Information, Location and Competitors
Table 19. Emmaus Medical Sickle Cell Anemia Therapeutics Major Business
Table 20. Emmaus Medical Sickle Cell Anemia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 21. Emmaus Medical SWOT Analysis
Table 22. Emmaus Medical Sickle Cell Anemia Therapeutics Product and Solutions
Table 23. Emmaus Medical Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Bluebird Bio Corporate Information, Location and Competitors
Table 25. Bluebird Bio Sickle Cell Anemia Therapeutics Major Business
Table 26. Bluebird Bio Sickle Cell Anemia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 27. Bluebird Bio SWOT Analysis
Table 28. Bluebird Bio Sickle Cell Anemia Therapeutics Product and Solutions
Table 29. Bluebird Bio Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. GlycoMimetics Corporate Information, Location and Competitors
Table 31. GlycoMimetics Sickle Cell Anemia Therapeutics Major Business
Table 32. GlycoMimetics Sickle Cell Anemia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 33. GlycoMimetics SWOT Analysis
Table 34. GlycoMimetics Sickle Cell Anemia Therapeutics Product and Solutions
Table 35. GlycoMimetics Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. DeuteRx Corporate Information, Location and Competitors
Table 37. DeuteRx Sickle Cell Anemia Therapeutics Major Business
Table 38. DeuteRx Sickle Cell Anemia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 39. DeuteRx SWOT Analysis
Table 40. DeuteRx Sickle Cell Anemia Therapeutics Product and Solutions
Table 41. DeuteRx Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Sancilio Pharmaceuticals Corporate Information, Location and Competitors
Table 43. Sancilio Pharmaceuticals Sickle Cell Anemia Therapeutics Major Business
Table 44. Sancilio Pharmaceuticals Sickle Cell Anemia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 45. Sancilio Pharmaceuticals SWOT Analysis
Table 46. Sancilio Pharmaceuticals Sickle Cell Anemia Therapeutics Product and Solutions
Table 47. Sancilio Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Global Blood Therapeutics Corporate Information, Location and Competitors
Table 49. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Major Business
Table 50. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 51. Global Blood Therapeutics SWOT Analysis
Table 52. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product and Solutions
Table 53. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Gamida Cell Corporate Information, Location and Competitors
Table 55. Gamida Cell Sickle Cell Anemia Therapeutics Major Business
Table 56. Gamida Cell Sickle Cell Anemia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 57. Gamida Cell SWOT Analysis
Table 58. Gamida Cell Sickle Cell Anemia Therapeutics Product and Solutions
Table 59. Gamida Cell Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Pfizer Corporate Information, Location and Competitors
Table 61. Pfizer Sickle Cell Anemia Therapeutics Major Business
Table 62. Pfizer Sickle Cell Anemia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 63. Pfizer SWOT Analysis
Table 64. Pfizer Sickle Cell Anemia Therapeutics Product and Solutions
Table 65. Pfizer Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Sangamo Biosciences Corporate Information, Location and Competitors
Table 67. Sangamo Biosciences Sickle Cell Anemia Therapeutics Major Business
Table 68. Sangamo Biosciences Sickle Cell Anemia Therapeutics Total Revenue (USD Million) (2017-2018)
Table 69. Sangamo Biosciences SWOT Analysis
Table 70. Sangamo Biosciences Sickle Cell Anemia Therapeutics Product and Solutions
Table 71. Sangamo Biosciences Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Global Sickle Cell Anemia Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 73. Global Sickle Cell Anemia Therapeutics Revenue Share by Players (2015-2020)
Table 74. Global Sickle Cell Anemia Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 75. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Regions (2015-2020)
Table 76. North America Sickle Cell Anemia Therapeutics Revenue by Countries (2015-2020)
Table 77. North America Sickle Cell Anemia Therapeutics Revenue Market Share by Countries (2015-2020)
Table 78. Europe Sickle Cell Anemia Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 79. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 80. South America Sickle Cell Anemia Therapeutics Revenue by Countries (2015-2020)
Table 81. South America Sickle Cell Anemia Therapeutics Revenue Market Share by Countries (2015-2020)
Table 82. Middle East and Africa Sickle Cell Anemia Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 83. Middle East and Africa Sickle Cell Anemia Therapeutics Revenue Market Share by Countries (2015-2020)
Table 84. Global Sickle Cell Anemia Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 85. Global Sickle Cell Anemia Therapeutics Revenue Share by Type (2015-2020)
Table 86. Global Sickle Cell Anemia Therapeutics Revenue Forecast by Type (2021-2025)
Table 87. Global Sickle Cell Anemia Therapeutics Revenue by Application (2015-2020)
Table 88. Global Sickle Cell Anemia Therapeutics Revenue Share by Application (2015-2020)
Table 89. Global Sickle Cell Anemia Therapeutics Revenue Forecast by Application (2021-2025)
Table 90. Global Sickle Cell Anemia Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Sickle Cell Anemia Therapeutics Picture
Figure 2. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type in 2019
Figure 3. Blood Transfusion Picture
Figure 4. Pharmacotherapy Picture
Figure 5. Bone Marrow Transplant Picture
Figure 6. Sickle Cell Anemia Therapeutics Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Others Picture
Figure 10. Global Sickle Cell Anemia Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Sickle Cell Anemia Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Sickle Cell Anemia Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Sickle Cell Anemia Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Sickle Cell Anemia Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Sickle Cell Anemia Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Sickle Cell Anemia Therapeutics Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Sickle Cell Anemia Therapeutics Revenue Market Share in 2019
Figure 19. Global Top 10 Players Sickle Cell Anemia Therapeutics Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Sickle Cell Anemia Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 23. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Regions in 2018
Figure 24. North America Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 25. Europe Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. South America Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. North America Sickle Cell Anemia Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 30. North America Sickle Cell Anemia Therapeutics Revenue Market Share by Countries in 2019
Figure 31. USA Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Canada Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Europe Sickle Cell Anemia Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Sickle Cell Anemia Therapeutics Revenue Market Share by Countries in 2019
Figure 36. Germany Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. UK Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. France Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. Russia Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Italy Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue Market Share by Countries in 2019
Figure 43. China Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Japan Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Korea Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. India Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. South America Sickle Cell Anemia Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 49. South America Sickle Cell Anemia Therapeutics Revenue Market Share by Countries in 2019
Figure 50. Brazil Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Sickle Cell Anemia Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Sickle Cell Anemia Therapeutics Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. UAE Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. Global Sickle Cell Anemia Therapeutics Revenue Share by Type (2015-2020)
Figure 59. Global Sickle Cell Anemia Therapeutics Revenue Share by Type in 2019
Figure 60. Global Sickle Cell Anemia Therapeutics Market Share Forecast by Type (2021-2025)
Figure 61. Global Blood Transfusion Revenue Growth Rate (2015-2020)
Figure 62. Global Pharmacotherapy Revenue Growth Rate (2015-2020)
Figure 63. Global Bone Marrow Transplant Revenue Growth Rate (2015-2020)
Figure 64. Global Sickle Cell Anemia Therapeutics Revenue Share by Application (2015-2020)
Figure 65. Global Sickle Cell Anemia Therapeutics Revenue Share by Application in 2019
Figure 66. Global Sickle Cell Anemia Therapeutics Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Sickle Cell Anemia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Sickle Cell Anemia Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Sickle Cell Anemia Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Sickle Cell Anemia Therapeutics Revenue Market Forecast (2021-2025)
Figure 74. Europe Sickle Cell Anemia Therapeutics Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. South America Sickle Cell Anemia Therapeutics Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Sickle Cell Anemia Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
鎌状赤血球貧血治療薬の世界市場（～2026年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…- 鎌状赤血球の世界市場（～2026年） The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some fac…
- 貧血治療薬の世界市場（～2026年） Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia. The iron deficiency anemia market segment accounted for the…
- 貧血治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Anemia Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 14180 million by 2025, from USD 11960 million in 2019. The Anemia Drugs market repor…
- 鎌状赤血球症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Sickle Cell Disease Drug Market The global Sickle Cell Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Sickle Cell Disease Drug Scope and Market Size Sickle Cell Diseas…